Trial intelligence / Profile preview

Bioequivalence of Atripla Liquid vs Tablet

NCT00862823Phase 4Completed

Sponsor
University of Alabama at Birmingham
Start
Feb 2009
Primary completion
Feb 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tenofovir disoproxil fumarate in human immunodeficiency virus type 1 infection (HIV-1), sponsored by University of Alabama at Birmingham. Started Feb 2009; status: completed.

02

Drugs

tenofovir disoproxil fumarate
03

Conditions

human immunodeficiency virus type 1 infection (HIV-1)

Beyond the preview

Go deeper on NCT00862823.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00862823.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call